Sun Pharmaceutical Industries Ltd. recently announced interim results from a Phase 2 study of interleukin-23 (IL-23) inh...
Dr. Reddy’s has announced positive topline results from its Phase 2b study of PPC-06 (formerly referred to as...
Recently, MyvalTM received the coveted CE approval. Meril now becomes the first Indian company to market and distribute ...
CliniVantage Healthcare Technologies Inc. is a comprehensive healthcare platform that delivers various PaaS-based health...
Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep fa...
The Centre for Cellular and Molecular Platforms (C-CAMP), India’s premier bio-innovation hub recently signed an Le...
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) ...
Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cance...
Dyadic International, a global biotechnology company focused on further improving and applying its proprietary C1 g...
Dalvkot Wound Care (DWC), a one-of-its-kind wound care centre, has launched its first dedicated wound care centre at Vyd...
Glenmark Pharmaceuticals Ltd has announced that it has appointed Dr. Yasir Rawjee as the Chief Executive Officer of Glen...
Glenmark Therapeutics has announced a co-promotion agreement with Otonomy, a biopharmaceutical company dedicated to the ...
SIFI, the Italian leader in the development of therapeutic solutions to treat ophthalmic disorders and global pharmaceut...
Alchem International Private Limited ("Alchem"), a privately held pharmaceutical company focused on the production of ph...
mfine, a health-tech AI startup from India, has raised $17.2 million in Series B funding. The i...
Alembic Pharmaceuticals Limited recently announced that the company has received approval from the US Food & Drug Ad...
M3, Inc. of Japan announced acquisition of a majority stake of India based Neuroglia Health Private Limited (NHPL), a le...
New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for r...
